沃森生物(300142.SZ)拟出资4.5亿元发起设立云南创沃生物产业投资基金

Core Viewpoint - Watson Bio (300142.SZ) announced the establishment of the Yunnan Chuangwo Biological Industry Investment Fund, with a target size of 1 billion yuan, to focus on synthetic biology, biomanufacturing, and biotechnology sectors [1] Group 1: Investment Details - The board of directors approved the partnership agreement with Guotou Chuangyi Industrial Fund Management Co., Ltd., Yuxi State-owned Capital Operation Co., Ltd., and Central Enterprise Rural Industry Investment Fund Co., Ltd. [1] - Watson Bio will contribute 450 million yuan as a limited partner in the fund [1] Group 2: Strategic Implications - The investment aligns with national bio-economy development plans, creating multiple opportunities for the company to capture industry benefits [1] - The collaboration with Guotou Chuangyi will enable the company to rapidly expand business channels and access high-quality market opportunities and partners [1] - Direct participation in fund operations will allow the company to engage closely with quality targets in the relevant fields, facilitating strategic mergers and acquisitions [1]